Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Oral Testosterone Undecanoate with Finasteride
NCT00842751Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jul 2009
- Primary completion
- Nov 2009
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of testosterone undecanoate in male contraception (3 arms), sponsored by University of Washington. Primary endpoints: Maximum Testosterone Concentration at 12 hours, Serum Dihydrotestosterone Concentration at 12 hours and 1 more. Started Jul 2009; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
male contraception
Beyond the preview
Go deeper on NCT00842751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842751.